News

The satisfaction of healthcare payers, patients and physicians with generic imatinib

2017-04-24 With the begining of the era of tyrosine kinase inhibitors (TKIs), chronic myeloid leukaemia (CML) became a chronic disease, in which good responding patients usually… Read More »

Pure red cell aplasia in a CKD patient after treatment with epoetin zeta

2017-04-21 Authors from the Versilia and Manzoni Hospitals in Italy report the case of a patient who developed pure red cell aplasia (PRCA) following subcutaneous administration… Read More »

Ways to reduce drug costs in Australia

2017-04-19 Drug costs in Australia are increasing at an alarming rate. This is driven mainly by expensive biological therapies, antiviral therapies for HIV and hepatitis C… Read More »

Doctors want more details in biosimilars labelling

2017-04-12 In the European Union (EU), labels (Summaries of Product Characteristics, SmPCs) for biosimilars and their reference products are, in many instances, almost identical despite different… Read More »

AES position statement on substitution of generic anti-epileptics

2017-04-12 A paper by the American Epilepsy Society (AES) discusses how the society’s position on generics substitution of anti-epileptic drugs has changed according to the results… Read More »

Biosimilar rituximab in biological naïve rheumatoid arthritis patients

2017-04-10 Cost remains a major constraint in the use of originator biologicals in rheumatology in developing countries, paving the way for ever increasing usage of biosimilars.… Read More »

Reasons for the success of a generics company in the Sudan market

2017-04-07 An exploratory, qualitative study carried out by colleagues from the University of Khartoum (Sudan) and Abertay University (UK) examined the reasons behind the success of… Read More »

Immunogenicity of biologicals: the role of post-translational modifications

2017-04-05 Although produced under strict quality control(s) nascent endogenous proteins and glycoproteins (P/GP) are structurally heterogeneous and subject to further structural changes throughout their in vivo… Read More »

Pharmacists prefer generic OTC medicines

2017-04-03 In the US, the use of generics has been lacking due to hesitation from consumers over whether generics are as safe and effective as brand-name… Read More »

Effectiveness of ESAs in treating anaemia in kidney disease and cancer patients

2017-03-31 Erythropoiesis-stimulating agents (ESAs) are biological analogues of human erythropoietin used for the treatment of anaemia associated with chronic kidney disease (CKD) and chemotherapy treatment in… Read More »

Page 1 of 49 1 2 3 4 5 Next »... 49
Go Back Print